Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Savara Inc
(NQ:
SVRA
)
4.480
-0.240 (-5.08%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Savara Inc
< Previous
1
2
3
Next >
Savara Reports First Quarter Financial Results and Provides Business Update
May 15, 2023
From
Savara Inc.
Via
Business Wire
Savara Announces New Employment Inducement Grant
May 05, 2023
From
Savara Inc.
Via
Business Wire
Savara Announces New Employment Inducement Grant
March 31, 2023
From
Savara Inc.
Via
Business Wire
Savara Reports Fourth Quarter / Year-End 2022 Financial Results and Provides Business Update
March 30, 2023
From
Savara Inc.
Via
Business Wire
Savara to Present at the Oppenheimer 33rd Annual Healthcare Conference
March 06, 2023
From
Savara Inc.
Via
Business Wire
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
February 28, 2023
From
Savara Inc.
Via
Business Wire
Savara Announces New Leadership Appointments
February 14, 2023
From
Savara Inc.
Via
Business Wire
Savara Announces New Employment Inducement Grant
January 20, 2023
From
Savara Inc.
Via
Business Wire
Savara Announces New Employment Inducement Grant
November 22, 2022
From
Savara Inc.
Via
Business Wire
Savara Reports Third Quarter 2022 Financial Results and Provides Business Update
November 10, 2022
From
Savara Inc.
Via
Business Wire
Savara to Participate in Three Upcoming Investor Conferences
November 09, 2022
From
Savara Inc.
Via
Business Wire
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
September 14, 2022
From
Savara Inc.
Via
Business Wire
Savara Presented Data at the European Respiratory Society (ERS) International Congress 2022
September 06, 2022
From
Savara Inc.
Via
Business Wire
Savara to Present at H.C. Wainwright 24th Annual Global Investment Conference
September 01, 2022
From
Savara Inc.
Via
Business Wire
Savara Announces Resignation of Chief Medical Officer
August 26, 2022
From
Savara Inc.
Via
Business Wire
Savara Awarded Promising Innovative Medicine (PIM) Designation in the United Kingdom (UK) for Molgramostim Nebulizer Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
August 25, 2022
From
Savara Inc.
Via
Business Wire
Savara Reports Second Quarter 2022 Financial Results and Provides Business Update
August 11, 2022
From
Savara Inc.
Via
Business Wire
Savara Announces Acceptance of Three Abstracts at the European Respiratory Society (ERS) International Congress 2022
July 11, 2022
From
Savara Inc.
Via
Business Wire
Savara Awarded Innovation Passport in United Kingdom (UK) for Molgramostim Nebulizer Solution (Molgramostim), a Novel Investigational Inhaled Biologic
June 16, 2022
From
Savara Inc.
Via
Business Wire
Savara to Present at Jefferies Healthcare Conference
June 01, 2022
From
Savara Inc.
Via
Business Wire
Savara to Present at H.C. Wainwright Global Investment Conference
May 17, 2022
From
Savara Inc.
Via
Business Wire
Savara Reports First Quarter 2022 Financial Results and Provides Business Update
May 11, 2022
From
Savara Inc.
Via
Business Wire
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
April 26, 2022
From
Savara Inc.
Via
Business Wire
Savara Announces Debt Refinancing of $26.5M Credit Facility With Silicon Valley Bank
April 22, 2022
From
Savara Inc.
Via
Business Wire
Savara Reports Fourth Quarter / Year-End 2021 Financial Results and Provides Business Update
March 30, 2022
From
Savara Inc.
Via
Business Wire
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
March 16, 2022
From
Savara Inc.
Via
Business Wire
Savara to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
January 04, 2022
From
Savara Inc.
Via
Business Wire
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
December 02, 2021
From
Savara Inc.
Via
Business Wire
Savara to Participate in Two Upcoming Investor Healthcare Conferences
November 15, 2021
From
Savara Inc.
Via
Business Wire
Savara Reports Third Quarter 2021 Financial Results and Provides Business Update
November 12, 2021
From
Savara Inc.
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.